Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
4.450
-0.210 (-4.51%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
28
29
Next >
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
April 03, 2023
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.
Via
Benzinga
5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More
April 03, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...
Via
Benzinga
Largest Psychedelic Stocks -3.4% In March
April 02, 2023
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 31, 2023
March 31, 2023
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
March 30, 2023
Via
Benzinga
Where Compass Pathways Stands With Analysts
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2023
March 29, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 28, 2023
March 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
March 27, 2023
Via
Benzinga
10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch
March 27, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
Cannabis Category Performances Ranged From +8.6% To -7.0% This Week
March 25, 2023
The 5 categories in the cannabis sector perform quite differently from each other and this week was a prime example.
Via
Talk Markets
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via
Benzinga
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026
March 24, 2023
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:
Via
Benzinga
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
March 21, 2023
This is the third article of a three-part series, you can find the first and
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via
Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
Via
Benzinga
The "Rags-To-Riches" Portfolio: An Update
March 18, 2023
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
March 15, 2023
Via
Benzinga
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression
March 14, 2023
COMPASS Pathways' (NASDAQ: CMPS) Phase 2b study of synthetic psilocybin COMP360 paired with psychological support for Treatment-Resistant Depression (TR
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
March 13, 2023
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.